{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T01:57:47Z","timestamp":1791424667395,"version":"4.3.3"},"reference-count":45,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2009,11,4]],"date-time":"2009-11-04T00:00:00Z","timestamp":1257292800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["bpspubs.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["British J Pharmacology"],"published-print":{"date-parts":[[2009,12]]},"abstract":"<jats:p>\n                    <jats:bold>Background and purpose:\u2002<\/jats:bold>\n                    There is a strong correlation between cytochrome P450 (P450)\u2010dependent arachidonic acid metabolism and the pathogenesis of cardiac hypertrophy. Several aryl hydrocarbon receptor (AhR) ligands were found to alter P450\u2010dependent arachidonic acid metabolism. Here, we have investigated the effect of 3\u2010methylcholanthrene (3\u2010MC) and benzo(a)pyrene (BaP), two AhR ligands, on the development of cardiac hypertrophy.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Experimental approach:\u2002<\/jats:bold>\n                    Male Sprague Dawley rats were injected (i.p.) daily with either 3\u2010MC (10\u2003mg\u00b7kg\n                    <jats:sup>\u22121<\/jats:sup>\n                    ) or BaP (20\u2003mg\u00b7kg\n                    <jats:sup>\u22121<\/jats:sup>\n                    ) for 7 days. Then hearts were removed, and the heart to body weight ratio and the gene expression of the hypertrophic markers and P450 genes were determined. Levels of arachidonic acid metabolites were determined by liquid chromatography\u2010electron spray ionization\u2010mass spectrometry.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Key results:\u2002<\/jats:bold>\n                    Both 3\u2010MC and BaP increased the heart to body weight ratio as well as the hypertrophic markers, atrial natriuretic peptide and brain natriuretic peptide. 3\u2010MC and BaP treatment increased the gene expression of CYP1A1, CYP1B1, CYP2E1, CYP4F4, CYP4F5 and soluble epoxide hydrolase. Both 3\u2010MC and BaP treatments increased the dihydroxyeicosatrienoic acids (DHETs)\u2003:\u2003epoxyeicosatrienoic acids (EETs) ratio and the 20\u2010hydroxyeicosatetraenoic acid (20\u2010HETE)\u2003:\u2003total EETs ratio. Treatment with benzo(e)pyrene, an isomer of BaP that is a poor ligand for the AhR, did not induce cardiac hypertrophy in rats, confirming the role of AhR in the development of cardiac hypertrophy. Treatment with the \u03c9\u2010hydroxylase inhibitor, HET0016, significantly reversed BaP\u2010induced cardiac hypertrophy.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Conclusions and implications:\u2002<\/jats:bold>\n                    3\u2010MC and BaP induce cardiac hypertrophy by increasing the ratio of DHETs\u2003:\u2003EETs and\/or the ratio of 20\u2010HETE\u2003:\u2003total EETs, through increasing soluble epoxide hydrolase activity.\n                  <\/jats:p>","DOI":"10.1111\/j.1476-5381.2009.00461.x","type":"journal-article","created":{"date-parts":[[2009,11,4]],"date-time":"2009-11-04T08:51:20Z","timestamp":1257324680000},"page":"1808-1819","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":65,"title":["3\u2010Methylcholanthrene and benzo(a)pyrene modulate cardiac cytochrome P450 gene expression and arachidonic acid metabolism in male Sprague Dawley rats"],"prefix":"10.1111","volume":"158","author":[{"given":"Mona E","family":"Aboutabl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beshay NM","family":"Zordoky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayman OS","family":"El\u2010Kadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,11,30]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.105.008185"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0024-3205(01)01241-3"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1002\/jbt.10"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.ede.0000181310.65043.2f"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(19)38526-6"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1157\/13087900"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2002-35392"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.32.8.840"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.106.009498"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.104.002253"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1006\/taap.1997.8360"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1093\/toxsci\/61.1.187"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1080\/00498250500356373"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1096\/fj.05-4341fje"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.30.9.1022"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.abb.2004.04.021"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12012-008-9027-x"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1080\/03602530600632063"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.pharmtox.45.120403.100045"},{"key":"e_1_2_8_21_1","doi-asserted-by":"crossref","first-page":"12912","DOI":"10.1016\/S0021-9258(18)31472-8","article-title":"Formation of 19(S)\u2010, 19(R)\u2010, and 18(R)\u2010hydroxyeicosatetraenoic acids by alcohol\u2010inducible cytochrome P450 2E1","volume":"268","author":"Laethem RM","year":"1993","journal-title":"J Biol Chem"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1006\/taap.1998.8468"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1006\/meth.2001.1262"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(19)52451-6"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2008.08.008"},{"key":"e_1_2_8_26_1","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1016\/S0022-3565(25)20768-6","article-title":"Microsomal cytochrome P450 peroxygenase metabolism of arachidonic acid in guinea pig liver","volume":"278","author":"McCallum GP","year":"1996","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00428-002-0659-0"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng.129"},{"key":"e_1_2_8_29_1","doi-asserted-by":"crossref","first-page":"19503","DOI":"10.1016\/S0021-9258(18)41804-2","article-title":"Beta\u2010naphthoflavone induction of a cytochrome P\u2010450 arachidonic acid epoxygenase in chick embryo liver distinct from the aryl hydrocarbon hydroxylase and from phenobarbital\u2010induced arachidonate epoxygenase","volume":"267","author":"Nakai K","year":"1992","journal-title":"J Biol Chem"},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-2952(99)00310-X"},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.R400004200"},{"key":"e_1_2_8_32_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.106.013839"},{"key":"e_1_2_8_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(18)34848-8"},{"key":"e_1_2_8_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(20)82244-3"},{"key":"e_1_2_8_35_1","doi-asserted-by":"crossref","first-page":"3387","DOI":"10.1016\/S0021-9258(17)41874-6","article-title":"Purification and biochemical characterization of two major cytochrome P\u2010450 isoforms induced by 2,3,7,8\u2010tetrachlorodibenzo\u2010p\u2010dioxin in chick embryo liver","volume":"269","author":"Rifkind AB","year":"1994","journal-title":"J Biol Chem"},{"key":"e_1_2_8_36_1","first-page":"216","article-title":"Downregulation of the atrial natriuretic peptide\/natriuretic peptide receptor\u2010C system in the early stages of diabetic retinopathy in the rat","volume":"11","author":"Rollin R","year":"2005","journal-title":"Mol Vis"},{"key":"e_1_2_8_37_1","doi-asserted-by":"publisher","DOI":"10.1006\/abbi.1998.0651"},{"key":"e_1_2_8_38_1","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.08-2060"},{"key":"e_1_2_8_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0041-008X(02)00035-2"},{"key":"e_1_2_8_40_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1681.1997.tb01778.x"},{"key":"e_1_2_8_41_1","doi-asserted-by":"publisher","DOI":"10.1139\/y95-022"},{"key":"e_1_2_8_42_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1099-0461(1999)13:1<29::AID-JBT4>3.0.CO;2-X"},{"key":"e_1_2_8_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)99016-0"},{"key":"e_1_2_8_44_1","doi-asserted-by":"publisher","DOI":"10.1096\/fj.02-0138com"},{"key":"e_1_2_8_45_1","doi-asserted-by":"publisher","DOI":"10.1006\/taap.1996.8068"},{"key":"e_1_2_8_46_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.108.023077"}],"container-title":["British Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1476-5381.2009.00461.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1476-5381.2009.00461.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T21:06:15Z","timestamp":1739394375000},"score":1,"resource":{"primary":{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/10.1111\/j.1476-5381.2009.00461.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11,30]]},"references-count":45,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["10.1111\/j.1476-5381.2009.00461.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1476-5381.2009.00461.x","archive":["Portico"],"relation":{},"ISSN":["0007-1188","1476-5381"],"issn-type":[{"value":"0007-1188","type":"print"},{"value":"1476-5381","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,11,30]]},"assertion":[{"value":"2009-11-30","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}